Systematic review evaluates the safety and effectiveness of FMT in Parkinson's disease, suggesting potential benefits.
To evaluate the efficacy and safety of fecal microbiota transplantation (FMT) in Parkinson’s disease (PD) through pooled quantitative analysis of clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Tudella et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: